@anniecl
Original 2007 biopsy and conservative surgery: Dr Lance Read at BSW in Temple
Recent 2023 biopsy: Dr Nolan Jenkins at Midtown Oral in Austin (2023)
If I were going through with the radical resection and fibular flap, I would have stayed with Dr. Jenkins. I am confident in him as a surgeon, and with his experience with ameloblastoma surgery in specific.
At MD Anderson in Houston, Dr Ann Gillenwater is heading up the team for my ameloblastoma. There were a lot of hoops to jump through before I started the dabrafenib-trametenib drug treatment targeting the BRAF V600E mutation this past Tuesday. MDA did the genetic screening after getting the pathology slides from the biopsy transferred to them.
I am not aware of any other hospital/doctor in the USA who is currently treating ameloblastoma with targeted therapy, and I think I'm the first for MDA.
As far as I know Stanford did one research case study (ie one person) treating ameloblastoma with the dabrafenib-trematenib treatment I am on. It worked at shrinking the tumor and regrowing bone. I haven't seen a long-term followup.
The biggest ameloblastoma targeted treatment study I could find was out of Israel and came out last year - still small with only 12 patients using targeted drug treatment (half got dabrafenib-trametenib, half just got dabrafenib) 100% showed significant tumor shrinkage and bone regrowth. Again, no long-term data.
According to my oncologist at MDA, the dabrafenib-trametenib combo typically has fewer side effects than straight dabrafenib - but that's based on use in melanoma and other cancers.
Side effects for me so far are mostly just being more tired. The first day I had trouble focusing, but that went away and could have been unrelated, or just the stress of waiting and anticipation coming to an end. On a positive note, the aching in my jaw has gotten less frequent.
Feel free to PM me if you would like to go into more detail.
Hi Tom, good luck with your targeted treatment.
Here is my story:
I was recently diagnosed with Ameloblastoma in my Maxilla bone, it took one year for the diagnosis after visiting several doctors (dentist, endodontist, internal medicine, oral/maxilla facial pain, orthodontist). By then, the tumor became large per CT scan done by ENT specialist at PAMF in Mountain View, CA.
The biopsy sample was tested by 2 different institutions to confirm it was Ameloblastoma benign tumor. The PAMF doctor who did my biopsy referred me to Stanford Oral/Maxillofacial Department in Feb 2023. It took them 3 months to give me a surgery date because it involved 2 surgeons from 2 different departments (1 surgeon from Oral/Maxillofacial Department for tumor dissection and 1 from head/neck oncology department for reconstruction).
After the complex surgery for 10 hours, they did an emergency redo within 24 hours on flap because it was missing blood flow, I was able to recover with ups and downs for the flap to survive. Stanford pathology came back after 4 weeks saying it was Ameloblastic Carcinoma with no BRAF mutation. So Stanford medical oncologist mentioned that I had to go through surgery/radiation treatment and no chemo/medical treatment. I went through surgery by then, so radiation was the next step. But my Head/Neck Oncologist performed another CT & MRI and found out that another tumor split from main tumor and started eating bone in the skull base. So they had to perform another surgery before going radiation.
I finally went for second surgery with neurosurgeon to remove that newly discovered tumor and the same Head & Neck Oncologist to remove extra margins from the first surgery location. Radiation therapy was started after 5 weeks of second surgery and 11 weeks of first surgery. Radiation was planned for 33 sessions everyday M-F and now I am in recovery mode.
In Summary, here are the timelines I went through:
Jan 2022-Jan 2023: Dentist, Endodontist, Kaiser PCP, Kaiser Oral/Maxillofacial Pain MRI test, changed insurance because wasn't happy with Kaiser
Feb 2023: Orthodontist who discovered lost Maxilla bone, PAMF ENT doctor biopsy
Mar 2023: PAMF pathology, UTSW pathology, UCSF Head & Neck, UCSF MRI, UCSF biopsy slides review, all confirmed that Ameloblastoma benign tumor
Apr 2023: Stanford surgeons meetup, leg CT scans for reconstruction
May 2023: Stanford tumor resection & reconstruction surgery
June 2023: Stanford pathology confirmed that Benign turned into Carcinoma from removed bone tests and tumor mass tests
July 2023: Neurosurgeon skull base surgery
Aug 2023: Radiation started
Sep 2023: Radiation ended
Oct 2023-Current: Recovery